Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.

Dobish MC, Villalta F, Waterman MR, Lepesheva GI, Johnston JN. Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease. Org Lett. 2012 Dec 21; 14(24):6322-5.

View in: PubMed

subject areas

Animals
Chagas Disease
Cytochrome P-450 Enzyme System
Imidazoles
Mice
Molecular Structure
Oxadiazoles
Triazoles
Tropical Medicine
Trypanosoma cruzi

authors with profiles

Fernando Villalta

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support